Search Results - "Chakraborty, Rajshekar"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    MM-645 Updated OS of Patients With AL Amyloidosis After CAEL-101 by Sang Hughes, Michael, Pan, Samuel, Chakraborty, Rajshekar, Raikhelkar, Jayant, Maurer, Mathew S., Mapara, Markus Y., Eisenberger, Andrew, Lentzsch, Suzanne, Bhutani, Divaya

    Published in Clinical lymphoma, myeloma and leukemia (01-09-2024)
    “…Morbidity and mortality remain high in immunoglobulin light chain (AL) amyloidosis due to organ involvement despite hematologic remission. Few antiamyloid…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Depth of Pre-Treatment Immunoparesis Is an Important Prognostic Factor for Survival in Relapsed Multiple Myeloma by Chakraborty, Rajshekar, Rybicki, Lisa, Nakashima, Megan, Dean, Robert M., Faiman, Beth M., Samaras, Christy J., Rosko, Nathaniel, Valent, Jason, Anwer, Faiz

    Published in Blood (13-11-2019)
    “…Background: Suppression of uninvolved immunoglobulins [Ig], or immunoparesis, is associated with an inferior progression-free survival [PFS] and overall…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Rapid Infusion Daratumumab Is Safe in Patients with AL Amyloidosis by Rosko, Nathaniel, Mo, Hanjie, Rudoni, Joslyn, Siebenaller, Caitlin, Lee, Sarah S, Chakraborty, Rajshekar, Faiman, Beth M., Khouri, Jack, Mejia Garcia, Alex V., Samaras, Christy J., Anwer, Faiz, Valent, Jason

    Published in Blood (13-11-2019)
    “…Introduction: Daratumumab (DARA) is an anti-CD38 human monoclonal antibody FDA-approved for the treatment of multiple myeloma (MM) and has demonstrated…”
    Get full text
    Journal Article
  9. 9

    Role of Ibrutinib Based Regimen in Chronic Lymphocytic Leukemia by Sardar, Muhammad, Malik, Saad Ullah, Khan, Ali Younas, Sohail, Chaudhry Saad, Ahmad, Malik Qistas, Amin, Saher Nasir, Chakraborty, Rajshekar, McBride, Ali, Azharuddin, Muhammad, Sharon, David, Lee, Patrick, Faridi, Warda, Anwer, Faiz

    Published in Blood (29-11-2018)
    “…Background: Treatment of Chronic lymphocytic leukemia (CLL) depends on stage of disease, age, functional status, comorbidities and presence of cytogenetic…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13